Steve Schonfeld
PMCB icon

Steve Schonfeld’s PharmaCyte Biotech PMCB Stock Holding History

Steve Schonfeld’s Portfolio PMCB Stock Details PMCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7K Sell
1,417
-5
-0.4% -$72 ﹤0.01% 2451
2026
Q1 		$18K Buy
1,422
+44
+3% +$640 ﹤0.01% 2062
2025
Q4 		$19K Sell
1,378
-1
-0.1% -$17 ﹤0.01% 1934
2025
Q3 		$25.4K Hold
1,379
– – ﹤0.01% 2097
2025
Q2 		$28.6K Buy
1,379
+37
+3% +$784 ﹤0.01% 1915
2025
Q1 		$31.9K Sell
1,342
-11
-0.8% -$339 ﹤0.01% 2084
2024
Q4 		$40.3K Sell
1,353
-10
-0.7% -$328 ﹤0.01% 1882
2024
Q3 		$49.5K Buy
1,363
+116
+9% +$4.1K ﹤0.01% 1888
2024
Q2 		$46.5K Buy
1,247
+10
+0.8% +$409 ﹤0.01% 1940
2024
Q1 		$55.7K Buy
1,237
+16
+1% +$658 ﹤0.01% 1895
2023
Q4 		$50.1K Sell
1,221
-5
-0.4% -$206 ﹤0.01% 1669
2023
Q3 		$48.9K Sell
1,226
-11
-0.9% -$533 ﹤0.01% 1538
2023
Q2 		$67.2K Sell
1,237
-26
-2% -$1.48K ﹤0.01% 1784
2023
Q1 		$69.8K Sell
1,263
-63
-5% -$3.52K ﹤0.01% 1741
2022
Q4 		$73.8K Buy
1,326
+21
+2% +$1.14K ﹤0.01% 2228
2022
Q3 		$60K Sell
1,305
-74
-5% -$3.56K ﹤0.01% 2618
2022
Q2 		$59K Sell
1,379
-5
-0.4% -$208 ﹤0.01% 2205
2022
Q1 		$60K Sell
1,384
-216
-14% -$9.12K ﹤0.01% 2316
2021
Q4 		$76K Sell
1,600
-3,042
-66% -$159K ﹤0.01% 1915
2021
Q3 		$280K Buy
+4,642
New +$310K ﹤0.01% 1569

Other funds holding PMCB

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Equitec Proprietary Markets
Equitec Proprietary Markets Chicago, Illinois $400M AUM 66.98% 1-Year Est. Return

Steve Schonfeld's PMCB Position: Q2 2026 in Review

Steve Schonfeld reduced its PharmaCyte Biotech (PMCB) stake by 0.35% in Q2 2026, selling an estimated $72 and leaving 1,417 shares worth $20.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2451.

Steve Schonfeld first reported a position in PMCB in Q3 2021 and has held it in 20 quarters since. The position peaked at $280K in Q3 2021. 20 funds tracked by Wall St. Rank hold PMCB as of Q2 2026.

  • Steve Schonfeld held 1,417 shares of PharmaCyte Biotech worth $20.7K as of Q2 2026.
  • Steve Schonfeld sold 5 PharmaCyte Biotech shares in Q2 2026, an estimated $72.
  • PharmaCyte Biotech made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2451 holding.
  • Steve Schonfeld first reported a position in PharmaCyte Biotech in Q3 2021 and has held it in 20 quarters since.
  • Steve Schonfeld's PharmaCyte Biotech position peaked at $280K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.